|
Volumn 51, Issue 2, 2005, Pages 107-
|
Importance of screening and early detection of pulmonary hypertension and current treatment options
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMBRISENTAN;
ARGININE;
BERAPROST;
BOSENTAN;
CALCIUM CHANNEL BLOCKING AGENT;
DIPYRIDAMOLE;
DIURETIC AGENT;
ENDOTHELIN RECEPTOR ANTAGONIST;
ILOPROST;
NITROUS OXIDE;
PHOSPHODIESTERASE INHIBITOR;
PROSTACYCLIN;
SILDENAFIL;
SITAXSENTAN;
UNIPROST;
VASODILATOR AGENT;
WARFARIN;
CLINICAL PROTOCOL;
DISEASE COURSE;
DISEASE SEVERITY;
DOPPLER ECHOCARDIOGRAPHY;
DOPPLER FLOWMETRY;
DRUG INDICATION;
EARLY DIAGNOSIS;
EXERCISE TEST;
HUMAN;
HYPOXEMIA;
INCIDENCE;
LUNG FUNCTION TEST;
LUNG TRANSPLANTATION;
MIXED CONNECTIVE TISSUE DISEASE;
MORBIDITY;
NOTE;
OXYGEN THERAPY;
POSITIVE END EXPIRATORY PRESSURE;
PULMONARY HYPERTENSION;
SCREENING TEST;
TREATMENT INDICATION;
|
EID: 22144465774
PISSN: 00223859
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (1)
|
References (5)
|